Tag Archives: BIO International Convention

Reaction to the $1,000 Genome

Untitled-3 copy

System promises to sequence tens of thousands of human whole genomes a year in a single laboratory. What do the first customers think? Life science technology company Illumina recently launched a sequencing platform that it claims will enable the $1,000 genome. The HiSeq X™ Ten Sequencing System comprises 10 ultra-high-throughput sequencers which together can sequence more than 18,000 genomes per year, making human whole-genome sequencing more affordable and accessible than ever before. The system builds Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Biofuel by California

TheHill

A look at some of the Golden State biotechnology companies that are contributing to the development of biofuels and renewable chemicals CELLANA Cellana uses the most productive plants on earth—marine microalgae—to develop bioproducts. Algae photosynthetically produce a line of Omega-3 EPA and DHA oils, animal feed, and biofuel feedstocks. Cellana’s patented system of serial photobioreactors coupled with open ponds, enables low-cost, continuous production of diverse strains of microalgae. Since 2009, Cellana has operated a 6-acre, Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Bio-fueling the Navy

shutterstock_26191726

The research component is anchored by the renowned biotech programs at University of California San Diego (UCSD), the Salk Institute and Scripps Research, which make San Diego a hotbed of biotech innovation. These institutions concentrate biologists, biotech scientists, engineers, and specialists, who in turn attract the entrepreneurs that help convert the research into products and companies. However, it also takes real marketplace demand—often led by a few significant “early adopters”—to put a new technology to Read More >

Environmental & Industrial, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Convention Attendees Make the Call on Expanded Access

Bioethics Panel

The BIO International Convention kicked off Monday with an interactive session organized by the BIO Board Standing Committee on Bioethics: The Bioethics of Drug Development—You Make the Call. Attendees engaged in a real-time polling exercise addressing the many difficult issues related to expanded access using a mock case study of a company – iCures – dealing with an expanded access request. Moderator Steve Usdin, Senior Editor, BioCentury, led the panel through challenging issues in drug Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Seek and Destroy

shutterstock_27160801

Ubiquibodies combine the specificity of antibodies with the destruction signal of ubiquitinization. Stand by for targeted destruction of disease-causing proteins in the cell Proteins in a cell that are aged or otherwise damaged are recycled via the ubiquitin-proteasome pathway (UPP). The doomed protein is first tagged with a protein called ubiquitin, which acts like a molecular sign reading “destroy me”, and then broken down by the proteasome, which is the cell’s recycling center. This catabolism Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,